Skyrizi Injection
Product Images NDC 0074-8350

Product Visual Gallery

This gallery contains 86 technical images submitted to the FDA as part of the official labeling for Skyrizi (NDC 0074-8350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Skyrizi 01

Line graph depicting ACR20 response rate (%) over 24 weeks for two groups: Placebo (dotted line with open circles) and Risankizumab (solid line with squares). The x-axis shows visits from Baseline to Week 24, and the y-axis shows response rates from 0 to 100%. Risankizumab shows a higher response rate compared to placebo throughout the study period.*

FDA Label Image

Skyrizi 02

Illustration of a Skyrizi injection pen showing labeled components including the green activator button, gray hand grips, inspection window, white needle sleeve, needle, and a dark gray cap with a note not to remove it until ready to inject.*

FDA Label Image

Skyrizi 03

Instructional illustration titled 'STEP 1' showing a hand reaching to take a rectangular box from a shelf, depicting the first step in handling or preparing the product Skyrizi by AbbVie Inc.*

FDA Label Image

Skyrizi 04

Illustration showing step 2 of a procedure with a disposal container and components including a Skyrizi prefilled injector pen, an alcohol wipe, and cap, alongside an icon indicating hand washing.*

FDA Label Image

Skyrizi 05

The diagram illustrates step 3 of an injection process, showing recommended injectable areas for a medication. The areas highlighted include the abdomen around the navel and the upper outer thighs on both legs. An inset shows a hand pinching a section of skin on the abdomen, indicating preparation for injection.*

FDA Label Image

Skyrizi 06

An instructional illustration showing Step 4 of a process involving the Skyrizi injection device. The image highlights a close-up view of the device's mechanism, indicating a specific alignment or positioning action with arrows for guidance.*

FDA Label Image

Skyrizi 07

Instructional diagram showing the proper injection angle for Skyrizi administration, indicating a 90-degree angle for subcutaneous injection into the abdomen or thigh. The image highlights arm and leg positions with a close-up of the injection site.*

FDA Label Image

Skyrizi 08

An instructional illustration showing Step 6 of using a Skyrizi injection device. It depicts a hand holding the injector pressing down against the skin, with a timer icon indicating to hold for 15 seconds and a downward arrow symbolizing injection direction.*

FDA Label Image

Skyrizi 09

An instructional illustration showing a hand holding a prefilled injector pen for Skyrizi. The diagram highlights Step 7, indicating to press the injector's button a second time to activate it, with a yellow indicator shown as part of the injection process.*

FDA Label Image

Skyrizi 0a

An instructional illustration showing a hand holding a Skyrizi auto-injector pen with the needle end downward, positioned above a patient's skin. The other hand is pressing a cotton ball or gauze pad onto the skin below. A black arrow points upward from the skin to the injection site, indicating the injection direction or step sequence.*

FDA Label Image

Skyrizi 0b

An instructional illustration showing step 9 of a process involving pressing the top of a grey and white sharps disposal container with a hand holding a capped syringe, demonstrating safe disposal of the syringe into the container.*

FDA Label Image

Skyrizi 0c

FDA Label Image

Skyrizi 0d

An instructional diagram showing a Skyrizi prefilled syringe with and without its cardboard sleeve. Labels identify components including the finger grip, plunger rod, calibrated expiration date, needle cover, and needle guard covering after use, demonstrating proper handling steps.*

FDA Label Image

Skyrizi 0e

An instructional illustration labeled 'Step 1' showing a preparation tray with a syringe prefilled with medication, a small packet, and a close-up circle highlighting a powder substance. This diagram likely depicts the initial steps for preparing an injectable medication, such as Skyrizi, for administration.*

FDA Label Image

Skyrizi 0f

Instructional illustration showing Step 2 of the process for preparing or administering Skyrizi, a medication by AbbVie Inc. The image depicts a hand holding a syringe and another hand holding the medication vial or device, indicating connection or assembly by an arrow pointing right.*

FDA Label Image

Skyrizi 10

An instructional illustration labeled Step 3 demonstrating the recommended injectable areas for Skyrizi. The diagram shows a person’s lower back and upper thigh, with a marked yellow area indicating where injections can be administered. An inset close-up shows a hand in the injection position on the thigh.*

FDA Label Image

Skyrizi 11

An instructional illustration showing Step 4 for using a syringe-like applicator. It depicts a hand holding the device with the instruction to 'Check liquid' inside it. This is part of a usage guide for Skyrizi 150 mg/mL injectable solution by AbbVie Inc.*

FDA Label Image

Skyrizi 12

An instructional illustration showing Step 5 in a procedure. It depicts a hand holding a syringe with liquid, with an arrow indicating detachment of the syringe from a small attached component. The image suggests how to remove the syringe from this component during administration.*

FDA Label Image

Skyrizi 13

An instructional diagram related to the injection of Skyrizi. It shows a hand holding a syringe at a 45-degree angle, indicating the proper injection angle, with a magnified view illustrating the angle measurement relative to the skin.*

FDA Label Image

Skyrizi 14

Instructional illustration titled 'STEP 7' showing a hand holding a syringe at a 45-degree angle with the note 'Hold angle steady.' The image includes a close-up of the syringe's needle guard, indicating how to properly position the needle during administration.*

FDA Label Image

Skyrizi 15

An instructional illustration depicting a hand holding a syringe above a disposal container, labeled as Step 8. The image suggests safe syringe disposal as part of medication administration steps, without showing any specific text or product branding.*

FDA Label Image

Skyrizi 16

An instructional line drawing showing parts of a syringe for Skyrizi, including the plunger rod, finger grip, label with expiration date, needle cover, and needle guard covering the needle after use. This diagram illustrates the syringe components and safe needle handling.*

FDA Label Image

Skyrizi 17

An instructional illustration labeled Step 1 showing a sharps disposal container, two syringes, alcohol prep pads, and a magnified view of a hand holding an alcohol prep pad. It appears to depict preparation steps for an injection process.*

FDA Label Image

Skyrizi 18

An instructional graphic explaining a full dose of Skyrizi, indicating that it equals two injections given one after the other.*

FDA Label Image

Skyrizi 19

An instructional diagram titled 'Step 2' showing the recommended injectable areas on the front of the thighs and the abdomen below the waist for Skyrizi administration. The illustration includes arrows pointing to these areas and a close-up image of a hand applying a medication patch or injection with a dotted circle on the skin.*

FDA Label Image

Skyrizi 1a

An instructional warning image advising to pick an injection site at least 1 inch away from the first site when using a second syringe and emphasizing not to inject into the same site.*

FDA Label Image

Skyrizi 1b

An instructional illustration showing Step 3 for preparing a Skyrizi injection. It depicts a hand holding a syringe vertically with the instruction to "Check liquid" visible alongside the syringe, demonstrating the step to inspect the liquid inside before use.*

FDA Label Image

Skyrizi 1c

Instructional diagram showing Step 4 of a process, where a hand is holding a syringe and an arrow indicates pulling the syringe cap off. The illustration highlights the action of removing the syringe cap before proceeding to the next step.*

FDA Label Image

Skyrizi 1d

An instructional illustration showing a hand holding a syringe, with an inset detail emphasizing a 45-degree angle for injection. This appears to be part of a step-by-step guide for administering Skyrizi, a product by AbbVie Inc.*

FDA Label Image

Skyrizi 1e

An instructional illustration showing Step 6 for administering an injection of Skyrizi. It depicts a hand holding a syringe at a steady 45-degree angle with a needle guard in place, directed towards an injection site on the abdomen. The image emphasizes maintaining the angle steady during injection.*

FDA Label Image

Skyrizi 1f

Instructional graphic showing Step 7 of an injection process for Skyrizi. It indicates that 2 injections are required, with two syringe icons depicted.*

FDA Label Image

Skyrizi 20

Illustration showing Step 8 of a process involving the use of a syringe. The image depicts a hand holding a syringe over a disposal container with a lid, guiding the syringe into the container, likely indicating safe disposal of the syringe.*

FDA Label Image

Skyrizi 21

An instructional front view illustration of the Skyrizi on-body injector showing labeled parts: adhesive material, status light, gray start button with a warning not to touch until ready to inject, gray door with a notice not to close without the prefilled cartridge inside, medicine window, and pull tabs.*

FDA Label Image

Skyrizi 22

Illustration showing the back view of a Skyrizi device component, labeled with parts including a clear plastic strip, needle cover, adhesive backing, and two green pull tabs (small section and large section). Warnings indicate the needle is inside under the needle cover and caution not to touch the needle or needle cover.*

FDA Label Image

Skyrizi 23

An instructional side view diagram illustrating the parts of a prefilled injector device for Skyrizi medication. It highlights the door latch, the gray door which should be slightly open, and warnings not to close the door without the prefilled cartridge inside. The needle cover and needle inside are indicated with cautions to avoid touching the needle cover or needle.*

FDA Label Image

Skyrizi 24

An instructional diagram of a Skyrizi prefilled cartridge showing labeled parts including the larger prefilled cartridge top, white plunger, medicine chamber, and smaller bottom tip. It also indicates the location of the expiration date on the cartridge label.*

FDA Label Image

Skyrizi 25

An instructional illustration labeled '1A' showing a hand pulling out a box from a shelf or storage unit and a calendar icon with a check mark, suggesting scheduling or timing instructions.*

FDA Label Image

Skyrizi 26

An instructional illustration showing a timer set to 45 seconds, alongside a box representing the product packaging. This likely indicates a recommended wait or step duration related to the Skyrizi medication process.*

FDA Label Image

Skyrizi 27

An instructional illustration showing how to open the box by lifting the top flap, indicated by a green arrow pointing upward. The image is associated with Skyrizi packaging instructions from AbbVie Inc.*

FDA Label Image

Skyrizi 28

An instructional illustration showing a sharps container with a lid, a prefilled syringe, alcohol prep pads, and a cotton ball. It includes an icon depicting hand washing, indicating proper hygiene procedures related to injection or medication administration for Skyrizi.*

FDA Label Image

Skyrizi 29

An instructional diagram showing a hand peeling back a tab or seal from a container. The image is marked with a blue label '1E' in the upper right corner. No branding or dosage information is visible.*

FDA Label Image

Skyrizi 2a

An instructional illustration showing a hand removing or lifting a component from a molded tray, indicated by a green arrow curving upwards. The image appears to guide the user on opening or accessing the product packaging or parts, with a blue label marked '1F' in the top right corner.*

FDA Label Image

Skyrizi 2b

An instructional diagram showing front and back views of a medical device, likely an autoinjector. The front view highlights the gray door and start button. The back view cautions that the needle is inside under a needle cover, emphasizing safe handling.*

FDA Label Image

Skyrizi 2c

Skyrizi 150 mg/mL solution for injection carton and vial label from AbbVie Inc. The packaging includes a box showing product name and strength with a vial containing clear liquid displayed beside it. The vial is labeled with concentration and brand name.*

FDA Label Image

Skyrizi 2d

An instructional diagram showing the back view of a Skyrizi autoinjector. It highlights a gray door being opened and a needle visibly positioned inside under the needle cover. The illustration guides users on how to access the needle cover before injection.*

FDA Label Image

Skyrizi 2e

Illustration showing a hand holding a Skyrizi prefilled cartridge highlighting the larger top tip and smaller bottom tip, indicating correct cartridge orientation for administration.*

FDA Label Image

Skyrizi 2f

Illustration for Skyrizi injection showing a two-step process: holding the injector with the smaller bottom tip pointing down, and cleaning the center of this smaller bottom tip with an antiseptic wipe, as part of preparation before administration.*

FDA Label Image

Skyrizi 30

An instructional illustration demonstrating how to insert the Straight 2D injection pen needle into a Skyrizi autoinjector device. It shows a hand positioning the needle straight down onto the pen with an arrow indicating insertion, and a close-up inset indicating a 'click' sound on successful attachment.*

FDA Label Image

Skyrizi 31

An instructional illustration showing a hand pressing down on the cap of a device with an arrow and the word "snap" indicating the cap is being removed or attached. The device likely relates to the Skyrizi product, manufactured by AbbVie Inc., but no drug-specific details are visible.*

FDA Label Image

Skyrizi 32

An instructional illustration showing recommended injection sites on a human body for Skyrizi. Green highlighted areas include the abdomen around the navel and the front of the thighs. The diagram is labeled with '3A' in the top right corner.*

FDA Label Image

Skyrizi 33

An instructional diagram showing a hand gripping and twisting a blue cap with arrows indicating a twisting motion, positioned above the waistband of pants. The illustration is labeled with '3B' in the upper right corner, suggesting a step in a usage or assembly instruction related to the product Skyrizi by AbbVie Inc.*

FDA Label Image

Skyrizi 34

An instructional diagram showing how to remove adhesives by peeling apart small and large sections to reveal the needle inside an activated injector. The image also displays a status light flashing blue on the injector accompanied by a "beep-beep-beep" sound indicator, illustrating proper activation steps for a Skyrizi injector device.*

FDA Label Image

Skyrizi 35

A safety instruction panel for the Skyrizi On-Body Injector. It advises users that if the status light flashes red and beeps are heard, the injector is malfunctioning and should not be used. It provides contact phone numbers for assistance and instructions to carefully remove the injector from the skin if attached.*

FDA Label Image

Skyrizi 36

Instructional illustration showing recommended injection sites for Skyrizi. The top panel demonstrates the abdomen area (belly) with directional arrows, while the bottom panel highlights the thigh area, both marked with dotted green lines to indicate injection zones.*

FDA Label Image

Skyrizi 37

An instructional illustration showing a hand pressing firmly on a Skyrizi injection device. The illustration includes a green arrow pointing left to right, indicating the direction to press firmly on the device, which is part of the self-administration process.*

FDA Label Image

Skyrizi 38

Illustration showing how to prepare the Skyrizi autoinjector for use. The image depicts a hand pressing on the device, with visual and audible cues indicated by a 'click' sound and a 'beep-beep-beep' to signal activation.*

FDA Label Image

Skyrizi 39

Instructional illustration showing a Skyrizi injection device secured in a holder or pocket. A timer icon with the number 5 and a green progress segment indicates to wait five minutes. A green-lit button detail on the device is highlighted, suggesting activation or readiness for use.*

FDA Label Image

Skyrizi 3a

An instructional illustration showing a close-up of a device button highlighted in green, indicating it emits a 'beep-beep-beep' sound. The image likely depicts a step in using a Skyrizi injection device by AbbVie Inc.*

FDA Label Image

Skyrizi 3b

An instructional diagram showing a person holding a Skyrizi prefilled syringe or autoinjector, with a green arrow indicating a step in the injection process. A bubble with the text 'beep-beep-beep' suggests an audio cue from the device during use.*

FDA Label Image

Skyrizi 3c

An instructional illustration showing a hand holding a Skyrizi autoinjector pen, positioned to administer the injection. A separate inset displays a capsule or pill shape, likely indicating the medicine form or part of the device. The image is labeled with '5A' in the top right corner.*

FDA Label Image

Skyrizi 3d

An instructional illustration showing a hand disposing of a used syringe into a sharps container. The container is labeled 'Sharps Container' and has a secure lid to safely hold the disposed syringe.*

FDA Label Image

Skyrizi 3e

A symbol key chart explaining the meanings of indicator lights and symbols for the Skyrizi On-Body Injector. It includes caution sign, flashing blue light (On/Ready), flashing green light (Injection has started), solid green light (Injection has finished), no light (Off/Finished), and flashing red light indicating the device is not working and directs users to call specified phone numbers.*

FDA Label Image

Skyrizi 3f

Skyrizi 150 mg/mL solution for injection in a clear vial with a purple cap, manufactured by AbbVie Inc. The vial is labeled 'STERILE EO' indicating sterilization method. The product name Skyrizi and concentration 150 mg/mL are prominently displayed on the label.*

FDA Label Image

Skyrizi 40

FDA Label Image

Skyrizi 41

A small label with the text 'STERILE' and 'EO' separated by a vertical line, indicating that the product is sterilized using ethylene oxide. No additional product-specific information is visible in the image.*

FDA Label Image

Skyrizi 42

FDA Label Image

Skyrizi 43

FDA Label Image

Skyrizi 44

FDA Label Image

Skyrizi 45

The image shows a rectangular black border with the bold, uppercase text "LOT" centered inside. This label likely represents a lot or batch number identifier, commonly found on pharmaceutical packaging such as that for Skyrizi by AbbVie Inc.*

FDA Label Image

Skyrizi 46

FDA Label Image

Skyrizi 47

FDA Label Image

Skyrizi 48

FDA Label Image

Skyrizi 49

FDA Label Image

Skyrizi 4a

FDA Label Image

Skyrizi 4b

Packaging label for Skyrizi 150 mg/mL solution for injection supplied by AbbVie Inc. The label shows the product name, strength, and includes detailed instructions with illustrations on how to use the Skyrizi-Pen. The packaging design features a blue and white theme with a red accent line and space for a pharmacy label and barcode.*

FDA Label Image

Skyrizi 4c

Packaging label for Skyrizi 150 mg/mL injection from AbbVie Inc. The label includes the proprietary name Skyrizi, the strength 150 mg/mL, and detailed instructions for use. The design features a blue sky background with clouds. The label also contains information about the contents and usage directions on the side panels.*

FDA Label Image

Skyrizi 4d

Packaging label for Skyrizi 150 mg/mL injection by AbbVie Inc. The label features a blue sky background with white clouds and includes the proprietary name Skyrizi, the strength 150 mg/mL, the generic name risankizumab-rzaa, and Rx only designation. It also shows areas for pharmacy label and barcode information, with illustrated instructions for injection preparation and administration on the side panel.*

FDA Label Image

Skyrizi 4e

Skyrizi 150 mg/mL injection carton from AbbVie Inc. The label includes the proprietary name, active ingredient risankizumab-rzaa, strength 150 mg/mL, and basic product information. The packaging also features step-by-step instructions with illustrations for preparing and administering the injection using a prefilled syringe. The design incorporates blue and white colors with branding elements and regulatory text.*

FDA Label Image

Skyrizi 4f

Skyrizi (risankizumab-rzaa) injection packaging label from AbbVie Inc. The label includes multiple strength options noted in the product data and contains detailed instructions for use. The design features predominantly blue and white colors with black text and includes spaces designated for pharmacy labeling and product information.*

FDA Label Image

Skyrizi 50

The image shows the packaging label for Skyrizi 150 mg/mL injection, a single-dose prefilled syringe containing risankizumab-rzaa. The label is primarily blue and white with red accents and includes detailed usage instructions with illustrations. It is labeled for prescription use only and produced by AbbVie Inc.*

FDA Label Image

Skyrizi 51

Packaging label for Skyrizi 150 mg/mL injection by AbbVie Inc., featuring an unfolded carton layout. The label includes dosing instructions, product name with strength, active ingredient risankizumab-rzaa, barcode, and safety warnings. The design uses a blue and white color scheme with text in English.*

FDA Label Image

Skyrizi 52

Packaging label for Skyrizi 150 mg/mL injection by AbbVie Inc. The label includes product name, active ingredient risankizumab-rzaa, dosage strength, a single-dose prefilled syringe, safety and preparation instructions, warnings, and manufacturer details. The design features blue and white colors with highlighted cautionary information and usage steps.*

FDA Label Image

Skyrizi 53

Skyrizi 150 mg/mL injection carton label showing a 1 x 2.4 mL prefilled cartridge with a 1-on-body injector. The label includes dosage strength of 360 mg/2.4 mL, active ingredient risankizumab-rzaa, usage instructions, storage warnings, and manufacturer AbbVie Inc. It also features a medication guide insert and cautions about not freezing or shaking the product.*

FDA Label Image

Skyrizi 54

Packaging label for Skyrizi 150 mg/2.4 mL (150 mg/mL) prefilled cartridge injection by AbbVie Inc. The carton includes patient and usage instructions, a blue and white color scheme, a photo of the on-body injector device, and safety and storage information. It states 'Rx only' and highlights the contents as a single-dose prefilled cartridge for subcutaneous use.*

FDA Label Image

Skyrizi 55

Label for Skyrizi injection, risankizumab-rzaa, 600 mg/10 mL (60 mg/mL) strength, for intravenous use only. The label states it is a single-dose vial and must be diluted prior to use. Manufactured by AbbVie Inc., North Chicago, IL, with storage instructions to refrigerate and protect from light. The label includes a barcode and Rx Only designation.*

FDA Label Image

Skyrizi 56

Packaging label for Skyrizi 600 mg/10 mL (60 mg/mL) injection by AbbVie Inc. The label indicates the product is for intravenous use only, requiring dilution before use. It comes as a single-dose 10 mL vial and includes storage instructions to refrigerate between 2°C to 8°C. The label includes warnings, ingredients, and manufacturer information with a barcode and US license number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.